Metastatic Cancer News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

In Young Women With Metastatic Breast Cancer, Kisqali Delays Tumor Growth And Relieves Symptoms - Forbes



Forbes
 
In Young Women With Metastatic Breast Cancer, Kisqali Delays Tumor Growth And Relieves Symptoms 
Forbes
At this year's San Antonio Breast Cancer Symposium, several reports on new treatments for advanced breast cancer caught my attention. In an impressive analysis presented by Dr. Debu Tripathy, ribociclib (Kisqali, Novartis) extended progression-free ...
Radius Investigational Drug Elacestrant (RAD1901) Continues to Show Promise in Advanced ER+ / HER2- Breast ... GlobeNewswire (press release)

all 191 news articles » 


A new weapon against bone metastasis? Princeton lab develops antibody to fight cancer - Princeton University



Princeton University
 
A new weapon against bone metastasis? Princeton lab develops antibody to fight cancer 
Princeton University
In the ongoing battle between cancer and modern medicine, some therapeutic agents, while effective, can bring undesirable or even dangerous side effects. ?Chemo saves lives and improves survival, but it could work much better if you eliminate unwanted ...
A new weapon against bone metastasis? Team develops antibody to fight cancer Medical Xpress
A new weapon against bone metastasis? EurekAlert (press release)

all 1 news articles » 


It's Metastatic - Now What? - WebMD (blog)



WebMD (blog)
 
It's Metastatic - Now What? 
WebMD (blog)
For many people living with cancer, ?metastatic? is a dreaded word. Hearing it means that cancer cells have broken away from the tumor and traveled or spread to lymph nodes or other organs, often significantly changing the prognosis. When people are ...

 


Doctors who give cancer patients false hope aren't helping them - Irish Times



Irish Times
 
Doctors who give cancer patients false hope aren't helping them 
Irish Times
A 2012 study, published in the New England Journal of Medicine (NEJM), found that 70 to 80 per cent of patients with either advanced bowel or lung cancer expected a cure that simply wasn't going to happen. Using data from the national Cancer Care ...

and more » 


Again, a PARP Inhibitor Has Potential in BRCA+ Breast Cancer - Medscape



Medscape
 
Again, a PARP Inhibitor Has Potential in BRCA+ Breast Cancer 
Medscape
SAN ANTONIO ? Talazoparib, a poly adenosine diphosphate ribose polymerase (PARP) inhibitor currently in development by Pfizer, has been shown to extend progression-free survival (PFS) compared with standard chemotherapy in women with metastatic breast ...
Pfizer's breast cancer drug improves progression-free survival in Phase 3 trial Pharmaceutical Business Review
Pfizer reports positive findings from new breast cancer drug trial Zenopa
PFS Improves with Talazoparib Use in BRCA-Positive Breast Cancer www.oncnursingnews.com/
Nasdaq  -pharmabiz.com 
all 6 news articles » 


Metastatic breast cancer: The black hole of cancer research and ... - EURACTIV



EURACTIV
 
Metastatic breast cancer: The black hole of cancer research and ... 
EURACTIV
A recent study put the cost of lung, breast, colorectal and prostate cancers at ?55,3 billion, representing 44% of the total economic cost of cancer, but there is a lack of knowledge on the burden of the disease at a later stage. [Dizzy Girl/Flickr ...

and more » 


An old drug for alcoholism finds new life as cancer treatment - Science - Science Magazine



Science Magazine
 
An old drug for alcoholism finds new life as cancer treatment - Science 
Science Magazine
By age 38, the patient's breast cancer had spread to her bones, a typically fatal turn of events. She became an alcoholic, and her doctors stopped all cancer treatment, instead giving her a drug to discourage her drinking. She died 10 years later ...

and more » 


Medication for metastatic breast cancer available in 2018 in Mexico - The Yucatan Times



The Yucatan Times
 
Medication for metastatic breast cancer available in 2018 in Mexico 
The Yucatan Times
MEXICO ? The Novartis pharmaceutical company reported that authorization was obtained from health officials to sell a drug to combat metastatic breast cancer (that extends to other parts of the body), which would allow a survival of up to five years ...

and more » 


ANGLE plc Announces Parsortix Potential in Metastatic Breast Cancer - Marketwired (press release)



ANGLE plc Announces Parsortix Potential in Metastatic Breast Cancer 
Marketwired (press release)
ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, is delighted to announce that the University of Southern California (USC) Norris Comprehensive Cancer Center yesterday presented results of extensive work with ANGLE's Parsortix ...

and more » 


Microbiome: Fusobacterium persistence in colorectal cancer - Nature.com



Microbiome: Fusobacterium persistence in colorectal cancer 
Nature.com
Several studies have found that fusobacteria are enriched in human colorectal cancers. To investigate their role in human colorectal cancers, a recent study analysed the microbiome of patient colorectal tissue and metastatic tumours and observed that ...